4th Quarter - Report
AMERICAN SOCIETY OF CLINICAL ONCOLOGY for AMERICAN SOCIETY OF CLINICAL ONCOLOGY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
—
Expenses
$32,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 21, 2009 | $32,000 | Replaced |
| 4th Quarter - Amendment | Apr 8, 2009 | $32,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
NIH/NCI Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | — |
| SHELAGH FOSTER | — |
Medicare/Medicaid MMM
Medicare Reimbursement of Chemotherapy Drugs Sustainable Growth Rate Comprehensive Cancer Care Improvement Act Medicare Coverage of Clinical Trials
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | — |
| SHELAGH FOSTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.